Avenue Therapeutics News

Company Name Stock Ticker Symbol Market Type
Avenue Therapeutics Inc ATXI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-3.63 -57.63% 2.665 11:49:39
Open Price Low Price High Price Close Price Prev Close
2.475 2.45 2.78 6.29
more quote information »

Recent News

Date Time Source Heading
10/07/202206:04EDGARNotice of Effectiveness (effect)
10/06/202223:00GLOBEAvenue Therapeutics Announces Pricing of $12 Million..
10/06/202216:07EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
10/06/202208:05EDGARSecurities Registration Statement (s-1/a)
10/05/202210:56TRMNAvenue Therapeutics Tanks After Public Offering
10/05/202206:01EDGARSecurities Registration Statement (s-1/a)
10/03/202208:00GLOBEUrica Therapeutics Appoints Seasoned Biotech Executive Jay..
9/30/202216:32EDGARCurrent Report Filing (8-k)
9/27/202216:10TRMNWhy Avenue Therapeutics Stock’s (NASDAQ:ATXI) 107% Moonshot..
9/23/202207:25TRMNAvenue Therapeutics (NASDAQ:ATXI) in Focus on 1-for-15..
9/22/202216:25GLOBEAvenue Therapeutics Announces Reverse Stock Split and..
8/22/202216:31EDGARInformation Statement - All Other (definitive) (def 14c)
8/15/202217:16EDGARQuarterly Report (10-q)
8/12/202216:20EDGARCurrent Report Filing (8-k)
8/10/202217:16EDGARProxy Statement - Other Information (preliminary) (pre 14c)
8/03/202216:34EDGARInitial Statement of Beneficial Ownership (3)
8/03/202216:33EDGARCurrent Report Filing (8-k)
7/29/202216:32EDGARCurrent Report Filing (8-k)
7/28/202216:31EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
5/17/202217:10EDGARInitial Statement of Beneficial Ownership (3)
5/16/202216:26EDGARQuarterly Report (10-q)
5/13/202216:50EDGARCurrent Report Filing (8-k)
3/31/202207:30GLOBEAbeona Therapeutics Announces Strategy Update and 2021..
3/30/202217:03EDGARCurrent Report Filing (8-k)
3/25/202216:21EDGARAnnual Report (10-k)
3/08/202217:02EDGARCurrent Report Filing (8-k)
3/01/202212:47SEEKNVEE and IMPP among mid-day movers
3/01/202211:27SEEKAvenue Therapeutics trebles in value on rising volume
2/16/202207:40EDGARCurrent Report Filing (8-k)
2/16/202206:21SEEKAvenue Therapeutics gets FDA panel's rejection on IV pain..
2/15/202222:00GLOBEAvenue Therapeutics Announces Outcome of FDA Advisory..
2/15/202207:05GLOBEAvenue Therapeutics Stock Trading Halted Today
2/14/202208:31EDGARStatement of Ownership (sc 13g)
2/11/202217:28EDGARCurrent Report Filing (8-k)
2/11/202214:30SEEKAvenue Therapeutics IV pain therapy to go under FDA review..
2/09/202215:32EDGARAmended Statement of Ownership (sc 13g/a)
1/07/202216:16EDGARCurrent Report Filing (8-k)
12/21/202116:30EDGARStatement of Changes in Beneficial Ownership (4)
12/21/202116:28EDGARStatement of Changes in Beneficial Ownership (4)
12/21/202116:25EDGARInitial Statement of Beneficial Ownership (3)
12/20/202117:07EDGARStatement of Changes in Beneficial Ownership (4)
12/17/202108:31EDGARSecurities Registration: Employee Benefit Plan (s-8)
12/16/202116:17EDGARCurrent Report Filing (8-k)
12/15/202112:00GLOBEAvenue Therapeutics Announces Closing of Public Offering of..
12/13/202109:24EDGARCurrent Report Filing (8-k)
12/13/202109:20EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/13/202106:02EDGARNotice of Effectiveness (effect)
12/13/202104:16SEEKAvenue Therapeutics under pressure after pricing $2M stock..
12/12/202120:00GLOBEAvenue Therapeutics Prices $2.0 Million Underwritten Public..
12/10/202117:25EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
Your Recent History
Avenue The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221007 16:04:42